Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Turkan Terkivatan"'
Autor:
Maryam Gholinejad, Egidius Pelanis, Davit Aghayan, Åsmund Avdem Fretland, Bjørn Edwin, Turkan Terkivatan, Ole Jakob Elle, Arjo J. Loeve, Jenny Dankelman
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-14 (2022)
Abstract Surgical process modelling is an innovative approach that aims to simplify the challenges involved in improving surgeries through quantitative analysis of a well-established model of surgical activities. In this paper, surgical process model
Externí odkaz:
https://doaj.org/article/e352e36eaf074ced99bc9fb0bacc012e
Autor:
Kostandinos Sideras, Katharina Biermann, Joanne Verheij, Bart R. Takkenberg, Shanta Mancham, Bettina E. Hansen, Hannah M. Schutz, Robert A. de Man, Dave Sprengers, Sonja I. Buschow, Maddy C. M. Verseput, Patrick P. C. Boor, Qiuwei Pan, Thomas M. van Gulik, Turkan Terkivatan, Jan N. M. Ijzermans, Ulrich H. W. Beuers, Stefan Sleijfer, Marco J. Bruno, Jaap Kwekkeboom
Publikováno v:
OncoImmunology, Vol 6, Iss 2 (2017)
Novel systemic treatments for hepatocellular carcinoma (HCC) are strongly needed. Immunotherapy is a promising strategy that can induce specific antitumor immune responses. Understanding the mechanisms of immune resistance by HCC is crucial for devel
Externí odkaz:
https://doaj.org/article/5f8e3ae8e9ab4fa2a3ac206ae24b7197
Autor:
Maarten G. Thomeer, Mirelle Broker, Joanne Verheij, Michael Doukas, Turkan Terkivatan, Diederick Bijdevaate, Robert A. De Man, Adriaan Moelker, Jan N. IJzermans
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 9 (2016)
Hepatocellular adenoma (HCA) is a rare, benign liver tumor. Discovery of this tumor is usually as an incidental finding, correlated with the use of oral contraceptives, or pregnancy. Treatment options have focused on conservative management for the s
Externí odkaz:
https://doaj.org/article/09f5104faf024e71bf71bdf6d31c761b
Autor:
Kunal Bhanot, E. Baris Akin, Nicos Kessaris, Diederik Kimenai, Robert C. Minnee, Gabriel C. Oniscu, Dirk L. Stippel, Turkan Terkivatan, T. C. Khe Tran, Frank J. M. F. Dor
Publikováno v:
Living Kidney Donation ISBN: 9783031095191
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::475d128dc024c0232a463befcaa5167c
https://doi.org/10.1007/978-3-031-09520-7_12
https://doi.org/10.1007/978-3-031-09520-7_12
Autor:
Liselotte S S, Ooms, Adriaan, Moelker, Joke I, Roodnat, Jan N M, Ijzermans, Mirza M, Idu, Turkan, Terkivatan
Publikováno v:
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation. 16(2)
Objectives: The aim of this study was to investigate the effects of antegrade balloon dilatation on ureteral strictures that developed after kidney transplant. Materials and Methods: The hospital databases of the Erasmus Medical Center (Rotterdam, Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ba49b0f7ea949bfb90fb1f11b1bcf653
https://pubmed.ncbi.nlm.nih.gov/29621961
https://pubmed.ncbi.nlm.nih.gov/29621961
Autor:
Kostandinos, Sideras, Katharina, Biermann, Joanne, Verheij, Bart R, Takkenberg, Shanta, Mancham, Bettina E, Hansen, Hannah M, Schutz, Robert A, de Man, Dave, Sprengers, Sonja I, Buschow, Maddy C M, Verseput, Patrick P C, Boor, Qiuwei, Pan, Thomas M, van Gulik, Turkan, Terkivatan, Jan N M, Ijzermans, Ulrich H W, Beuers, Stefan, Sleijfer, Marco J, Bruno, Jaap, Kwekkeboom
Publikováno v:
Oncoimmunology
Novel systemic treatments for hepatocellular carcinoma (HCC) are strongly needed. Immunotherapy is a promising strategy that can induce specific antitumor immune responses. Understanding the mechanisms of immune resistance by HCC is crucial for devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8fbbd0e2f268141face8c1eac54b44cf
https://pubmed.ncbi.nlm.nih.gov/28344887
https://pubmed.ncbi.nlm.nih.gov/28344887
Autor:
Martijn P. D. Haring, Arthur K. E. Elfrink, Christiaan A. J. Oudmaijer, Paul C. M. Andel, Alicia Furumaya, Nenke de Jong, Colin J. J. M. Willems, Thijs Huits, Julie M. L. Sijmons, Eric J. T. Belt, Koop Bosscha, Esther C. J. Consten, Mariëlle M. E. Coolsen, Peter van Duijvendijk, Joris I. Erdmann, Paul Gobardhan, Robbert J. de Haas, Tjarda van Heek, Hwai‐Ding Lam, Wouter K. G. Leclercq, Mike S. L. Liem, Hendrik A. Marsman, Gijs A. Patijn, Türkan Terkivatan, Babs M. Zonderhuis, Izaak Quintus Molenaar, Wouter W. te Riele, Jeroen Hagendoorn, Alexander F. M. Schaapherder, Jan N. M. IJzermans, Carlijn I. Buis, Joost M. Klaase, Koert P. de Jong, Vincent E. de Meijer
Publikováno v:
Hepatology Communications, Vol 7, Iss 1, Pp e2110-e2110 (2023)
Hepatocellular adenomas (HCAs) are benign liver tumors associated with bleeding or malignant transformation. Data on the indication for surgery are scarce. We analyzed indications and outcome of patients operated for HCAs 50 mm (52%), suspicion of (p
Externí odkaz:
https://doaj.org/article/5bc6211f44f94829bfd770f0d4b780d4
Autor:
Zhouhong Ge, Guoying Zhou, Lucia Campos Carrascosa, Erik Gausvik, Patrick P.C. Boor, Lisanne Noordam, Michael Doukas, Wojciech G. Polak, Türkan Terkivatan, Qiuwei Pan, R. Bart Takkenberg, Joanne Verheij, Joris I. Erdmann, Jan N.M. IJzermans, Maikel P. Peppelenbosch, Jaco Kraan, Jaap Kwekkeboom, Dave Sprengers
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 2, Pp 443-464 (2021)
Background & Aims: TIGIT is a co-inhibitory receptor, and its suitability as a target for cancer immunotherapy in HCC is unknown. PD1 blockade is clinically effective in about 20% of advanced HCC patients. Here we aim to determine whether co-blockade
Externí odkaz:
https://doaj.org/article/89506260ed7f4f479d3b7d6501af3e38
Autor:
Jeffrey A Lafranca, Mark van Bruggen, Hendrikus J A N Kimenai, Thi C K Tran, Türkan Terkivatan, Michiel G H Betjes, Jan N M IJzermans, Frank J M F Dor
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0153460 (2016)
BACKGROUND:Whether vascular multiplicity should be considered as contraindication and therefore 'extended donor criterion' is still under debate. METHODS:Data from all live kidney donors from 2006-2013 (n = 951) was retrospectively reviewed. Vascular
Externí odkaz:
https://doaj.org/article/01777331e48b4d698452cef11e601a96
Autor:
Inez K B Slagt, Jan N M Ijzermans, Laurents J Visser, Willem Weimar, Joke I Roodnat, Türkan Terkivatan
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e91211 (2014)
Urological complications after kidney transplantation are mostly related to the ureteroneocystostomy, often requiring interventions with additional costs, morbidity and mortality. Our aim was to assess risk factors for urological complications in dec
Externí odkaz:
https://doaj.org/article/d27429c6a6664fdc8039419c56b46d6d